• thesohoriots@lemmy.world
    link
    fedilink
    English
    arrow-up
    5
    ·
    5 days ago

    Unlike weight-loss drugs, Ozempic is widely covered by insurance plans for treating diabetes. Patients rarely pay full price. However, Novo said its new offering will expand availability for those who don’t have coverage, giving them access to a more affordable version of the drug.

    “People who don’t have coverage” aka off-label cash grab from people who don’t have diabetes. You have fun with that one, kids.